A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo

Hybridoma (Larchmt). 2008 Apr;27(2):65-9. doi: 10.1089/hyb.2007.0549.

Abstract

Affinity-matured human antibodies have demonstrated efficacy as countermeasures for exposure to botulinum neurotoxin (BoNT), which is the cause of the disease botulism category A select bioterror agent. Little is known, however, about the potential role of natural (un-mutated) antibodies in the protective immune response to BoNT. Here we describe the cloning of two human IgM antibodies that bind serotype A BoNT. Both are un-mutated IgM antibodies, consistent with an origin in naive B cells. One of the antibodies is able to fully neutralize a lethal dose of serotype A BoNT in vivo. These results suggest that the natural human antibody repertoire may play a role in protection from exposure to biological toxins.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Bacterial / administration & dosage
  • Antibodies, Bacterial / metabolism
  • Antibodies, Bacterial / physiology*
  • Binding Sites, Antibody
  • Botulinum Toxins / antagonists & inhibitors
  • Botulinum Toxins / immunology*
  • Botulinum Toxins / metabolism
  • Botulinum Toxins, Type A / antagonists & inhibitors
  • Botulinum Toxins, Type A / immunology*
  • Botulinum Toxins, Type A / metabolism
  • Botulism / immunology
  • Botulism / prevention & control
  • Cell Line, Tumor
  • Cells, Cultured
  • Clostridium botulinum / immunology*
  • Humans
  • Hybridomas
  • Immunoglobulin M / administration & dosage
  • Immunoglobulin M / metabolism
  • Immunoglobulin M / physiology*
  • Molecular Sequence Data

Substances

  • Antibodies, Bacterial
  • Immunoglobulin M
  • rimabotulinumtoxinB
  • Botulinum Toxins
  • Botulinum Toxins, Type A